Last Updated: June 26, 2024
bms-staging.com has 4 NS records, 2 A records, 0 AAAA records, 2 MX records, and 4 TXT records. Name servers for bms-staging.com are ns4.bms.com, ns3.bms.com, ns1.bms.com, ns2.bms.com. A records for bms-staging.com are 45.60.150.161, 45.60.170.161. MX records that process @bms-staging.com email are loki.bms.com, chimera.bms.com. We have observed bms-staging.com to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. Technology that may be in use at bms-staging.com includes globalsign. The website's description is: "bristol myers squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases."
Search DigitalStakeout ASI to find another asset.
45.60.150.161
45.60.170.161
No DNS AAAA records
loki.bms.com
chimera.bms.com
ns4.bms.com
ns3.bms.com
ns1.bms.com
ns2.bms.com
bms-staging.com. 300 IN TXT "globalsign-domain-verification=1542CCB5D7DF2FAEBD47C440EFC45391"
bms-staging.com. 300 IN TXT "globalsign-domain-verification=77AE34D8798C0F5A86AEE84F0EB13EFF"
bms-staging.com. 300 IN TXT "globalsign-domain-verification=C7DE3122FF18F392E1994BE244D04121"
bms-staging.com. 300 IN TXT "globalsign-domain-verification=C1841DE8E3A142713D1E39E93F24E3F2"
bms-staging.com has 2 subdomains in our inventory.
og:title: global biopharmaceutical company - bristol myers squibb
og:type: website
og:url: https://www.bms-staging.com/
og:image: https://www.bms-staging.com/assets/bms/us/en-us/images/bms-logo-social-default-card.jpg
og:description: bristol myers squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
{"data":{"cert_index":826993217,"cert_link":"https:\/\/ct.googleapis.com\/logs\/us1\/argon2024\/ct\/v1\/get-entries?start=826993217&end=826993217","leaf_cert":{"all_domains":["bms-staging.com","imperva.com"],"extensions":{"authorityInfoAccess":"CA Issuers - URI:http:\/\/secure.globalsign.com\/cacert\/gsatlasr3dvtlsca2024q1.crt\nOCSP - URI:http:\/\/ocsp.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1\n","authorityKeyIdentifier":"keyid:66:C0:C7:A3:9A:CD:FE:F3:EA:CE:4B:53:0B:61:5E:AF:33:05:B3:E1\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 1.3.6.1.4.1.4146.10.1.3\n CPS: https:\/\/www.globalsign.com\/repository\/","crlDistributionPoints":"Full Name:\n URI:http:\/\/crl.globalsign.com\/ca\/gsatlasr3dvtlsca2024q1.crl","ctlPoisonByte":true,"extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:imperva.com, DNS:bms-staging.com","subjectKeyIdentifier":"EA:A4:B4:5F:69:54:5C:03:7F:69:96:6E:FB:AC:C7:71:15:FB:0A:52"},"fingerprint":"91:4B:F7:6A:D0:A8:CC:DD:EE:2D:FF:C6:6C:BD:B5:84:1F:B5:A9:28","issuer":{"C":"BE","CN":"GlobalSign Atlas R3 DV TLS CA 2024 Q1","L":null,"O":"GlobalSign nv-sa","OU":null,"ST":null,"aggregated":"\/C=BE\/CN=GlobalSign Atlas R3 DV TLS CA 2024 Q1\/O=GlobalSign nv-sa","emailAddress":null},"not_after":1705474500,"not_before":1705388100,"serial_number":"1F6AA758A63E5B1C3A808EC3F2BC3BE","signature_algorithm":"sha256, rsa","subject":{"C":null,"CN":"imperva.com","L":null,"O":null,"OU":null,"ST":null,"aggregated":"\/CN=imperva.com","emailAddress":null}},"seen":1705388175.13917,"source":{"name":"Google 'Argon2024' log","url":"https:\/\/ct.googleapis.com\/logs\/us1\/argon2024\/"},"update_type":"PrecertLogEntry"},"message_type":"certificate_update"}